Frontiers in Oncology | Thoracic Oncology

Mini Review

Published on 29 Mar 2017

Antiangiogenesis for Advanced Non-Small-Cell Lung Cancer in the Era of Immunotherapy and Personalized Medicine

in Thoracic Oncology

Samer Tabchi
Normand Blais

Frontiers in Oncology

doi 10.3389/fonc.2017.00052

7,557 views
27 citations

Mini Review

Published on 27 Mar 2017

Update on the Treatment of Metastatic Squamous Non-Small Cell Lung Cancer in New Era of Personalized Medicine

in Thoracic Oncology

Sara Victoria Soldera
Natasha B. Leighl

Frontiers in Oncology

doi 10.3389/fonc.2017.00050

7,625 views
38 citations

Mini Review

Published on 20 Mar 2017

Current Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous Lung Cancer

in Thoracic Oncology

Barbara Melosky

Frontiers in Oncology

doi 10.3389/fonc.2017.00038

20,508 views
22 citations

Case Report

Published on 02 Mar 2017

Treating the Critically Ill with Radiotherapy: Lessons Learned from a Young Woman with Cardiac Angiosarcoma

in Thoracic Oncology

Emma C. Fields
Bryan Squires
Harry Lomas

Frontiers in Oncology

doi 10.3389/fonc.2017.00029

2,961 views
8 citations

Review

Published on 14 Feb 2017

Interventional Analgesic Management of Lung Cancer Pain

in Thoracic Oncology

Uri Hochberg
Maria Francisca Elgueta
Jordi Perez

Frontiers in Oncology

doi 10.3389/fonc.2017.00017

23,176 views
42 citations

Clinical Trial

Published on 20 Dec 2016

Phase 3 Randomized Low-Dose Paclitaxel Chemoradiotherapy Study for Locally Advanced Non-Small Cell Lung Cancer

in Thoracic Oncology

Hongmei Lin
Yuhchyau Chen
Anhui Shi
Kishan J Pandya
Rong Yu
Yannan Yuan
Jiancheng Li
Hang Li
Yingjie Wang
Tingyi Xia

Frontiers in Oncology

doi 10.3389/fonc.2016.00260

4,886 views
11 citations

Mini Review

Published on 14 Nov 2016

Recent Advances in Immunotherapy in Metastatic NSCLC

in Thoracic Oncology

Pranshu Bansal
Diaa Osman
Gregory N. Gan
George R. Simon
Yanis Boumber

Frontiers in Oncology

doi 10.3389/fonc.2016.00239

11,175 views
38 citations

Perspective

Published on 24 Oct 2016

Report on First International Workshop on Robotic Surgery in Thoracic Oncology

in Thoracic Oncology

Giulia Veronesi
Robert Cerfolio
Roberto Cingolani
Jens C. Rueckert
Luc Soler
Alper Toker
Umberto Cariboni
Edoardo Bottoni
Uberto Fumagalli
Franca Melfi

Frontiers in Oncology

doi 10.3389/fonc.2016.00214

8,514 views
30 citations

Case Report

Published on 24 Oct 2016

Definitive IMRT for Stage III Thymic Carcinoma: A Brief Report and Literature Review

in Thoracic Oncology

Sarah A. Dooley
Carryn M. Anderson

Frontiers in Oncology

doi 10.3389/fonc.2016.00219

3,493 views
4 citations

Mini Review

Published on 04 May 2016

Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC

in Thoracic Oncology

Pranshu Bansal
Diaa Osman
Gregory N. Gan
George R. Simon
Yanis Boumber

Frontiers in Oncology

doi 10.3389/fonc.2016.00112

10,395 views
30 citations

Clinical Trial

Published on 13 Jan 2016

Impact Study: MK-0646 (Dalotuzumab), Insulin Growth Factor 1 Receptor Antibody Combined with Pemetrexed and Cisplatin in Stage IV Metastatic Non-squamous Lung Cancer

in Thoracic Oncology

Chao H. Huang
Stephen K. Williamson
Prakash Neupane
Sarah A. Taylor
Ace Allen
Nora J. Smart
Adelina M. Uypeckcuat
Sarah Spencer
Jo Wick
Holly Smith

Frontiers in Oncology

doi 10.3389/fonc.2015.00301

4,607 views
11 citations

Editorial

Published on 30 Nov 2015

Novel Treatments for Thymoma and Thymic Carcinoma

in Thoracic Oncology

Arun Rajan
Heather Wakelee
Giuseppe Giaccone

Frontiers in Oncology

doi 10.3389/fonc.2015.00267

6,078 views
1 citation

Review

Published on 30 Sep 2015

Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions

in Thoracic Oncology

Zhuo Zhang
Nithya Ramnath
Sunitha Nagrath

Frontiers in Oncology

doi 10.3389/fonc.2015.00209

18,701 views
60 citations

Review

Published on 22 Sep 2015

Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer

in Thoracic Oncology

Annkathrin Hanssen
Sonja Loges
Klaus Pantel
Harriet Wikman

Frontiers in Oncology

doi 10.3389/fonc.2015.00207

14,328 views
67 citations

Original Research

Published on 26 May 2015

Trends and Characteristics of Young Non-Small Cell Lung Cancer Patients in the United States

in Thoracic Oncology

Anish Thomas
Yuanbin Chen
Tinghui Yu
Marko Jakopovic
Giuseppe Giaccone

Frontiers in Oncology

doi 10.3389/fonc.2015.00113

16,715 views
112 citations

Editorial

Published on 03 Feb 2015

The Treatment of Metastatic Non-Small Cell Lung Cancer in a New Era of Personalized Medicine

in Thoracic Oncology

Vera Hirsh

Frontiers in Oncology

doi 10.3389/fonc.2015.00020

6,177 views
2 citations

Original Research

Published on 28 Jan 2015

Prospective Validation Obtained in a Similar Group of Patients and with Similar High Throughput Biological Tests Failed to Confirm Signatures for Prediction of Response to Chemotherapy and Survival in Advanced NSCLC: A Prospective Study from the European Lung Cancer Working Party

in Thoracic Oncology

Thierry Berghmans
Lieveke Ameye
Jean-Jacques Lafitte
Benoît Colinet
Alexis Cortot
Ingrid CsToth
Stéphane Holbrechts
Jacques Lecomte
Céline Mascaux
Anne-Pascale Meert

Frontiers in Oncology

doi 10.3389/fonc.2014.00386

5,549 views
10 citations

Original Research

Published on 19 Dec 2014

Fanconi Anemia Repair Pathway Dysfunction, a Potential Therapeutic Target in Lung Cancer

in Thoracic Oncology

Wenrui Duan
Li Gao
Brittany Aguila
Arjun Kalvala
Gregory A. Otterson
Miguel A. Villalona-Calero

Frontiers in Oncology

doi 10.3389/fonc.2014.00368

8,336 views
32 citations

Review

Published on 09 Dec 2014

Promising Targets and Current Clinical Trials in Metastatic Squamous Cell Lung Cancer

in Thoracic Oncology

Mark D. Vincent

Frontiers in Oncology

doi 10.3389/fonc.2014.00320

6,953 views
5 citations

Clinical Case Study

Published on 08 Dec 2014

EGFR Mutation Positive Stage IV Non-Small-Cell Lung Cancer: Treatment Beyond Progression

in Thoracic Oncology

Katrijn Van Assche
Liesbeth Ferdinande
Yolande Lievens
Katrien Vandecasteele
Veerle Surmont

Frontiers in Oncology

doi 10.3389/fonc.2014.00350

34,874 views
14 citations

Mini Review

Published on 25 Nov 2014

Promising Targets and Current Clinical Trials in Metastatic Non-Squamous NSCLC

in Thoracic Oncology

Alona Zer
Natasha Leighl

Frontiers in Oncology

doi 10.3389/fonc.2014.00329

9,830 views
35 citations

General Commentary

Published on 10 Nov 2014

Good Syndrome, Bad Problem

in Thoracic Oncology

Bianca Martinez
Sarah K. Browne

Frontiers in Oncology

doi 10.3389/fonc.2014.00307

12,634 views
23 citations

Perspective

Published on 05 Nov 2014

Clinical Utility of Circulating Tumor Cells in ALK-Positive Non-Small-Cell Lung Cancer

in Thoracic Oncology

Vincent Faugeroux
Emma Pailler
Nathalie Auger
Melissa Taylor
Françoise Farace

Frontiers in Oncology

doi 10.3389/fonc.2014.00281

7,998 views
26 citations

Review

Published on 22 Oct 2014

Immunotherapy for Lung Cancer: Has it Finally Arrived?

in Thoracic Oncology

Ahmed A. Mostafa
Don G. Morris

Frontiers in Oncology

doi 10.3389/fonc.2014.00288

15,021 views
33 citations

1,913 articles

articles

Antiangiogenesis for Advanced Non-Small-Cell Lung Cancer in the Era of Immunotherapy and Personalized Medicine

Update on the Treatment of Metastatic Squamous Non-Small Cell Lung Cancer in New Era of Personalized Medicine

Current Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous Lung Cancer

Treating the Critically Ill with Radiotherapy: Lessons Learned from a Young Woman with Cardiac Angiosarcoma

Interventional Analgesic Management of Lung Cancer Pain

Phase 3 Randomized Low-Dose Paclitaxel Chemoradiotherapy Study for Locally Advanced Non-Small Cell Lung Cancer

Recent Advances in Immunotherapy in Metastatic NSCLC

Report on First International Workshop on Robotic Surgery in Thoracic Oncology

Definitive IMRT for Stage III Thymic Carcinoma: A Brief Report and Literature Review

Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC

Impact Study: MK-0646 (Dalotuzumab), Insulin Growth Factor 1 Receptor Antibody Combined with Pemetrexed and Cisplatin in Stage IV Metastatic Non-squamous Lung Cancer

Novel Treatments for Thymoma and Thymic Carcinoma

Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions

Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer

Trends and Characteristics of Young Non-Small Cell Lung Cancer Patients in the United States

The Treatment of Metastatic Non-Small Cell Lung Cancer in a New Era of Personalized Medicine

Prospective Validation Obtained in a Similar Group of Patients and with Similar High Throughput Biological Tests Failed to Confirm Signatures for Prediction of Response to Chemotherapy and Survival in Advanced NSCLC: A Prospective Study from the European Lung Cancer Working Party

Fanconi Anemia Repair Pathway Dysfunction, a Potential Therapeutic Target in Lung Cancer

Promising Targets and Current Clinical Trials in Metastatic Squamous Cell Lung Cancer

EGFR Mutation Positive Stage IV Non-Small-Cell Lung Cancer: Treatment Beyond Progression

Promising Targets and Current Clinical Trials in Metastatic Non-Squamous NSCLC

Good Syndrome, Bad Problem

Clinical Utility of Circulating Tumor Cells in ALK-Positive Non-Small-Cell Lung Cancer

Immunotherapy for Lung Cancer: Has it Finally Arrived?